Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The human tumor microbiome is composed of tumor type–specific intracellular bacteria

Science(2020)10.1126/science.aay9189Source: DataRank Database

The human tumor microbiome is composed of tumor type–specific intracellular bacteria is a research paper published in Science (2020). On theSindex it has a DataRank of 1.2. It has been cited 2,272 times.

N/A

1.2DataRank · unranked

Scored on demand from live citation data

Open Access2,272 citations

Download PDF

Cite:

Linked data & code

bioproject doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 85.03)OA: greenTopics (56)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

1.2

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (61)

Ilana Livyatan ORCID,Garold Fuks ORCID,Nancy Gavert ORCID,Yaara Zwang ORCID,Leore T. Geller ORCID

Live enrichment

PubMed:32467386 PMC:PMC7757858 OpenAlex:https://openalex.org/W3030942202

National Institutes of Health

Grant: 1R01CA219896-01A1

(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome

American Association for Cancer Research

Grant: SU2C-AACR-IRG-19-17

H2020 European Research Council

Grant: 818086

The tumor microbial communities: Characterization, effects and translational opportunities

United States-Israel Binational Science Foundation

Grant: 2013332

Israel Ministry of Science, Technology & Space

Grant: 3-11174

Israel Science Foundation

Grant: 2044/17

NCI NIH HHS

Grant: P30 CA033572

NCI NIH HHS

Grant: T32 CA009599

National Institutes of Health

Grant: 5P30CA033572-27

Developmental Funds

European Commission

Grant: 786344

Discovering microbiome-based disease risk factors

Israel Cancer Research Fund

Rising Tide Foundation

FWCI

85.03

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: other-oa

repositoryhttps://hdl.handle.net/11585/780581

publisherhttps://syndication.highwire.org/content/doi/10.1126/science.aay9189

publisherhttps://www.science.org/doi/pdf/10.1126/science.aay9189

journalhttps://doi.org/10.1126/science.aay9189

Fields of Study

Gut microbiota and healthCancer Research and TreatmentsProbiotics and Fermented Foods0301 basic medicine0303 health sciences03 medical and health sciencesBacteriaBreastColonFemaleHumansImmunotherapyLungMacrophagesMaleMicrobiotaNeoplasmsOvaryRNA, Ribosomal, 16S

MeSH Terms

BacteriaBreastColonFemaleHumansImmunotherapyLungMacrophagesMaleNeoplasmsOvaryRNA, Ribosomal, 16SMicrobiota

Keywords

BacteriaMicrobiomeIntracellularIntracellular parasiteBiologyHuman microbiomeComputational biologyMicrobiologyCell biologyBioinformaticsGeneticsMaleColonMacrophagesMicrobiotaOvaryBacteria; Breast; Colon; Female; Humans; Immunotherapy; Lung; Macrophages; Male; Neoplasms; Ovary; RNA, Ribosomal, 16S; MicrobiotaNeoplasmsRNA, Ribosomal, 16SHumansFemaleBreastImmunotherapyLung

Sustainable Development Goals

SDG 3: 3. Good healthSDG 13: 13. Climate actionSDG 0: Good health and well-being

Additional file 1 of Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer

10.6084/m9.figshare.14443107.v1figshare

Additional file 1 of Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer

10.6084/m9.figshare.14443107figshare

Additional file 9 of HOME-BIO (sHOtgun MEtagenomic analysis of BIOlogical entities): a specific and comprehensive pipeline for metagenomic shotgun sequencing data analysis

10.6084/m9.figshare.14913855.v1figshare

Additional file 9 of HOME-BIO (sHOtgun MEtagenomic analysis of BIOlogical entities): a specific and comprehensive pipeline for metagenomic shotgun sequencing data analysis

10.6084/m9.figshare.14913855figshare

Additional file 2 of Multi-omics of the esophageal microenvironment identifies signatures associated with progression of Barrett’s esophagus

10.6084/m9.figshare.15567531.v1figshare

Additional file 2 of Multi-omics of the esophageal microenvironment identifies signatures associated with progression of Barrett’s esophagus

10.6084/m9.figshare.15567531figshare

Additional file 1 of Antimicrobial peptides: mechanism of action, activity and clinical potential

10.6084/m9.figshare.16590552.v1figshare

Additional file 1 of Antimicrobial peptides: mechanism of action, activity and clinical potential

10.6084/m9.figshare.16590552figshare

Additional file 1 of Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma

10.6084/m9.figshare.16909587.v1figshare

Additional file 1 of Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma

10.6084/m9.figshare.16909587figshare

Additional file 1 of Species-resolved sequencing of low-biomass or degraded microbiomes using 2bRAD-M

10.6084/m9.figshare.19069903figshare

Additional file 1 of Species-resolved sequencing of low-biomass or degraded microbiomes using 2bRAD-M

10.6084/m9.figshare.19069903.v1figshare

Additional file 3 of Species-resolved sequencing of low-biomass or degraded microbiomes using 2bRAD-M

10.6084/m9.figshare.19069909.v1figshare

Additional file 3 of Species-resolved sequencing of low-biomass or degraded microbiomes using 2bRAD-M

10.6084/m9.figshare.19069909figshare

Additional file 1 of Mammary tumors alter the fecal bacteriome and permit enteric bacterial translocation

10.6084/m9.figshare.19313668.v1figshare

Additional file 1 of Mammary tumors alter the fecal bacteriome and permit enteric bacterial translocation

10.6084/m9.figshare.19313668figshare

Additional file 4 of Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis

10.6084/m9.figshare.20088194.v1figshare

Additional file 4 of Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis

10.6084/m9.figshare.20088194figshare

Additional file 5 of Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis

10.6084/m9.figshare.20088197.v1figshare

Additional file 5 of Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis

10.6084/m9.figshare.20088197figshare

Related Papers (10)

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

N/A

1.3DataRank · unranked

Science(2018)

co-citedsame journal

10.1126/science.aan3706

Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

N/A

0.975DataRank · unranked

Nature Medicine(2022)

co-cited

10.1038/s41591-021-01655-5

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

N/A

1.3DataRank · unranked

Science(2018)

co-citedsame journal

10.1126/science.aan4236

Cancer SLC43A2 alters T cell methionine metabolism and histone methylation

N/A

0.969DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2682-1

Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy

Science Translational Medicine(2021)

co-cited

10.1126/scitranslmed.aaz6314

Translocation of Oral Microbiota into the Pancreatic Ductal Adenocarcinoma Tumor Microenvironment

Microorganisms(2023)

co-cited

10.3390/microorganisms11061466

Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling

The Journal of Experimental Medicine(2020)

co-cited

10.1084/jem.20192282

Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction

N/A

0.873DataRank · unranked

Nature Metabolism(2020)

co-cited

10.1038/s42255-020-0219-4

Targeting cancer metabolism in the era of precision oncology

N/A

1.1DataRank · unranked

Nature Reviews Drug Discovery(2021)

co-cited

10.1038/s41573-021-00339-6

Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment

N/A

0.953DataRank · unranked

Cell(2021)

co-cited

10.1016/j.cell.2021.09.019

The human tumor microbiome is composed of tumor type–specific intracellular bacteria

FAIR Checklist

DataRank Breakdown

Authors (61)

Funding (12 grants)

Impact

Open Access

Topics

Linked Datasets (25)

Annotations (Europe PMC)

Related Papers (10)